Print Page  Close Window


SEC Filings

8-K
OREXIGEN THERAPEUTICS, INC. filed this Form 8-K on 05/03/2019
Entire Document
 


Case 18-10518-KG     Doc 1081    Filed 04/29/19     Page 5 of 11

 

In re: Orexigen Therapeutics, Inc.

   Case No. 18-10518 (KG)

Debtor

   Reporting Period: March 1, 2019 - March 31, 2019

 

MOR - 1a

Schedule of Disbursements by Debtor Entity (l)

For the Period: March 1, 2019 - March 31, 2019

(Unaudited)

 

$ USD ‘000s

Debtor

  

March 1, 2019 - March 31, 2019

     Cumulative
Since Filing

 

 

Orexigen Therapeutics, Inc.

         $                                     785          $        139,426  
    

 

 

 

  

 

 

 

Total

         $                                     785          $        139,426  

 

 
       

Notes:

 

(1) The Schedule of Disbursements is presented on a book basis.